NeuroOne OneRF Study Reports Immediate Pain Relief in 14 of 15 Patients
NeuroOne said its OneRF device delivered immediate pain relief in 14 of 15 patients in an initial study.
Related stories
SK Hynix shares fall 5%
M impact | EQUITY | Oct 30, 2026, 12:00 AM UTC
US stock futures decline
L impact | EQUITY | Oct 30, 2026, 12:00 AM UTC
Origin Energy Q1 APLNG Revenue Jumps on Higher Prices and Data Centre Demand
M impact | EQUITY | Oct 30, 2026, 12:00 AM UTC
Seatrium Secures FPSO Integration Contract Worth Over S$200 Million
Seatrium secured an FPSO integration contract valued at over S$200 million from SBM Offshore.
M impact | EQUITY | Oct 30, 2026, 12:00 AM UTC
Global market picture: S&P 500 -0.62%, Nasdaq 100 -1.54%; EUR/USD +0.26%, WTI +0.83%
Global market picture. US index futures: S and P futures is down 0.62 percent, Nasdaq futures is down 1.54 percent, Dow futures is up 0.06 percent and Russell futures is down 0.03
M impact | EQUITY | Oct 30, 2026, 12:00 AM UTC
Teck Resources Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Oct 29, 2026, 11:59 PM UTC